TCERG1L-AS1

Across TCGA pan-cancer cohorts, TCERG1L-AS1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of TCERG1L-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where TCERG1L-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TCERG1L-AS1 is over-expressed in tumor, although a few such as KICH and UCEC show the opposite, repressed pattern.

THCA, KIRP, and KIRC are the cancer types where TCERG1L-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TCERG1L-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	+1.364	<.001	10	view →
KIRP	All	All	+0.478	<.001	8	view →
KIRC	Male	All	+0.354	<.001	8	view →
KICH	All	All	−0.180	.002	5	view →
UCEC	All	All	−0.579	<.001	4	view →
PRAD	All	All	−0.231	<.001	2	view →
LUAD	Female	II,III,IV	−0.197	.034	2	view →
BRCA	Female	All	−0.152	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

TCERG1L-AS1–THCA

Open the THCA breakdown →